[EN] TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS [FR] TÉTRAAZA-CYCLOPENTA[A]INDÉNYLE ET LEUR UTILISATION EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS
[EN] TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS [FR] TÉTRAAZA-CYCLOPENTA[A]INDÉNYLE ET LEUR UTILISATION EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS
Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators
申请人:Ares Trading S.A.
公开号:EP2607364A1
公开(公告)日:2013-06-26
The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
Tetraaza-cyclopenta[a]indenyl and their use as Positive Allosteric Modulators
申请人:Merck Patent GmbH
公开号:US20150018343A1
公开(公告)日:2015-01-15
The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS
申请人:Merck Patent GmbH
公开号:EP2794608A1
公开(公告)日:2014-10-29
US9403835B2
申请人:——
公开号:US9403835B2
公开(公告)日:2016-08-02
[EN] TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS<br/>[FR] TÉTRAAZA-CYCLOPENTA[A]INDÉNYLE ET LEUR UTILISATION EN TANT QUE MODULATEURS ALLOSTÉRIQUES POSITIFS
申请人:MERCK PATENT GMBH
公开号:WO2013091773A1
公开(公告)日:2013-06-27
The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.